Live tape
Top 8, mentions 7d28,664NVDA13,567 mentions▲ +0.04ANT4,101 mentions▲ +0.07GOOGL2,923 mentions▲ +0.04SPY2,255 mentions▲ +0.05QQQ1,780 mentions▲ +0.03SPCX1,546 mentions▲ +0.07AMD1,345 mentions▲ +0.06AAPL1,147 mentions▲ +0.04

Equity · Healthcare

CAI

NASDAQ

Caris Life Sciences (CAI)

17.62 USD −6.53% vs prior close Nov 20, 2026
Caris Life Sciences, Inc. price graph
64 sessions
40 10 24 Aug 20 Nov

The line runs 26.12 USD on 24 August through 17.62 USD on 20 November, on a scale from 10 to 40. Days the market did not trade hold the previous close, flat.

Market cap
5.1B USD
P/E (TTM)
2.1
Revenue, year to Dec 2025
812.0M USD
EPS, diluted, year to Dec 2025
−3.22 USD
52-week range
14.56 USD – 36.16 USD
Avg volume
277.4K
Mentions, 30 days
1

as of Nov 20, 2026

Have Caris Life Sciences (CAI) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, Caris Life Sciences insiders reported 4 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 15 May 2026.

Form 4, 90 days to 22 Nov 2026, newest reported trade 22 Sep 2026

0buys
4sells
$27.20Mnet sold
3other filings
Have Caris Life Sciences (CAI) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
22 Sep 2026Denton John RusselSee RemarksSell7,500239K USD
17 Sep 2026Brille Brian JSee RemarksSell400,00012.1M USD
04 Sep 2026Spetzler David BaxleyPresidentSell119,2123.0M USD
03 Sep 2026Spetzler David BaxleyPresidentSell478,00011.9M USD
Sold4 open-market sales1,004,712$27.20M
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Caris Life Sciences (CAI) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
17 Sep 2026Brille Brian JSee RemarksOption exercise400,000976K USD
04 Sep 2026Spetzler David BaxleyPresidentOption exercise250,000610K USD
03 Sep 2026Spetzler David BaxleyPresidentOption exercise1,000,0002.4M USD

Which funds hold Caris Life Sciences (CAI)?

8 of the 45 institutional funds we track reported a Caris Life Sciences position for the quarter ended 30 Sep 2026 — a combined 587.7M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Caris Life Sciences (CAI)?
FundPositionSharesValueShares q/q
AQR Capital ManagementAdded8,210,498251.5M USD+13,791.8%
D. E. Shaw & Co.Added7,218,295221.1M USD+3,424.2%
Millennium ManagementTrimmed1,565,22547.9M USD−28.9%
Renaissance TechnologiesHeld (±25%)656,50020.1M USD+15.6%
Citadel AdvisorsAdded653,41320.0M USD+119.4%
Two Sigma InvestmentsAdded558,87217.1M USD+1,456.7%
Tudor Investment CorpAdded162,9745.0M USD+62.4%
Balyasny Asset ManagementNew position160,9594.9M USD
Coatue ManagementExited
Duquesne Family OfficeExited

What has been filed or recorded for Caris Life Sciences (CAI)?

The filings we hold for Caris Life Sciences, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 21 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Caris Life Sciences (CAI)?
And
21 Oct 2026Fails to deliverShares failed to deliver166,598 shares5.2M USD notional · 0.058% of shares out
13 Oct 2026Fails to deliverShares failed to deliver138,306 shares4.1M USD notional · 0.048% of shares out
08 Oct 2026Fails to deliverShares failed to deliver3,461 shares94K USD notional · 0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 0.05 USDRevenue $275M
30 Sep 2026FinancialsTotal assets1.3B USDat period end
30 Sep 2026FinancialsTotal equity639.5M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 0.00 USDRevenue $264M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.00 USDRevenue $216M
31 Dec 2025Annual reportFY 2025 reportedEPS −3.22 USDRevenue $812M
31 Dec 2025FinancialsRevenue812.0M USDfiscal year
31 Dec 2025FinancialsNet income−68.1M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−3.22 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.08 USDRevenue $217M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −7.97 USDRevenue $181M
31 Mar 2025Quarterly earningsQ1 2026 reportedEPS −3.57 USDRevenue $121M
31 Dec 2024Annual reportFY 2025 reportedEPS −10.66 USDRevenue $412M

What is Reddit saying about Caris Life Sciences (CAI)?

Reddit mentioned CAI 1 times in the 30 days to 22 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 22 November 2026.

30-day window, Method

1mentions, 30 days
1communities

How do Reddit mentions of Caris Life Sciences (CAI) compare with its price?

Share ↗
1 mentions

Which subreddits are talking about Caris Life Sciences (CAI)?

30 days

Which subreddits are talking about Caris Life Sciences (CAI)?
CommunityShareMentionsNet sentiment
r/wallstreetbets100%1+0.39

What do people ask about Caris Life Sciences (CAI)?

From live data
What did Caris Life Sciences shares close at?17.62

Caris Life Sciences closed at 17.62 USD on 20 Nov 2026, down 6.53% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Caris Life Sciences’ market cap?5.1B

Caris Life Sciences is worth 5.1B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Caris Life Sciences’ P/E ratio?2.1

Caris Life Sciences has a price-to-earnings ratio of 2.1, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Caris Life Sciences’ revenue?812.0M

Caris Life Sciences reported revenue of 812.0M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Caris Life Sciences insiders bought or sold shares recently?4 sales

In the 90 days to 22 Nov 2026, Caris Life Sciences insiders reported 4 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 15 May 2026. A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Caris Life Sciences?8 of 45

8 of the 45 funds we track reported a Caris Life Sciences position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, D. E. Shaw & Co. and Millennium Management. See Funds

When did Caris Life Sciences last report earnings?0.05

Caris Life Sciences last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.05 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about Caris Life Sciences?1 mentions

Caris Life Sciences was mentioned 1 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings
  10. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words